Overview
Mei Ling is a Nurse Practitioner in New York, New York. Ms. Ling is highly rated in 2 conditions, according to our data. Her top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Upper Tract Urothelial Carcinoma (UTUC).
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1275 York Ave Fl 18, New York, NY 10065
Weill Medical College Of Cornell
Karen Pekle is a Nurse Practitioner in New York, New York. Ms. Pekle is highly rated in 2 conditions, according to our data. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
NY Office
David Mendoza is a Nurse Practitioner in New York, New York. Mr. Mendoza is highly rated in 1 condition, according to our data. His top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Office
Alison Hergianto is a Nurse Practitioner in New York, New York. Ms. Hergianto is highly rated in 1 condition, according to our data. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer and Lung Nodules.
Frequently Asked Questions about Mei Ling, NP
How do I make an appointment with Mei Ling, NP?
You can book an appointment with Mei Ling, NP by calling their office at 212-639-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Mei Ling, NP a top-rated expert for Muscle Invasive Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Mei Ling, NP is classified as an Distinguished expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Mei Ling, NP specialize in?
While Mei Ling, NP is a Nurse Practitioner, they have specific expertise in Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Upper Tract Urothelial Carcinoma (UTUC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nurse Practitioner.
Does Mei Ling, NP accept my insurance?
Mei Ling, NP accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-639-2000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerMs. Ling isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerMs. Ling isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Upper Tract Urothelial Carcinoma (UTUC)